Medical Innovation in the Changing Healthcare Marketplace Conference Summary (2002) / Chapter Skim
Currently Skimming:
Executive Summary
Executive Summary
Pages 1-8
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 1... ...
Two contrasting diseases were discussed at the conferencecardiovascular disease and metastatic melanoma. For cardiovascular disease, there have been major advances in acute care, drugs, devices, and preventive measures over the last half-century, and these have resulted in significantly reduced morbidity and mortality.
|
From page 2... ...
There has been inadequate investment in information processing systems, and there has been insufficient emphasis on teamwork in care delivery. The inadequate investment in information processing systems led one speaker at the conference to say that there is a need for the federal government to take a leadership role in fostering a health care information infrastructure.
|
From page 3... ...
Further, science is identifying new ways of using existing drugs. Increased use of prescription pharmaceuticals also reflects in part a greater understanding of their value offsetting other health care costs (Lichtenberg, 1996,2001)
|
From page 4... ...
Based on the average cost of medical treatment for cardiovascular disease and the cost of providing behavioral advice, and assuming that an extra year of life is valued at $100,000, the speaker demonstrated that the return on medical care is very high, about 4:1, and the return on behavioral changes is much higher, about 30:1. In the context of escalating costs associated with innovation, one speaker concluded that new technologies (most of which tend to be expensive for example, Left Ventricular Assist Devices for heart failure)
|
From page 5... ...
This lack of objective assessment is ascribed to the passivity of payers of health care services. At the same time, physicians and patients have been aggressive about demanding the latest technology, while Congress and the courts are reluctant to control access to new medical technologies.
|
From page 6... ...
Congressional reluctance to address health care issues. Congress has understandably become reactive to health care issues because the issues are complex, political capital is difficult to gain from health care legislation, and congressional opinion is fragmented on health care issues.
|
From page 7... ...
, balancing quality of care choices against out-of-pocket expenses. Moreover, almost certainly they will have to assume more of the cost burden, leading to further scrutiny of health care costs.
|
From page 8... ...
June 9, 2001. Back to health care costs.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.